Sirtuin 1 Activation Reduces Transforming Growth Factor-β1–Induced Fibrogenesis and Affords Organ Protection in a Model of Progressive, Experimental Kidney and Associated Cardiac Disease
Yanling Zhang(St. Michael's Hospital), Richard E. Gilbert(St. Michael's Hospital)
Cited by 63
Related Papers
Inhibition of Protein Kinase C–β by Ruboxistaurin Preserves Cardiac Function and Reduces Extracellular Matrix Production in Diabetic Cardiomyopathy
|Circulation Heart Failure|2009|116
Sodium-Glucose Linked Cotransporter-2 Inhibition Does Not Attenuate Disease Progression in the Rat Remnant Kidney Model of Chronic Kidney Disease
|PLoS ONE|2016|79
Load-independent effects of empagliflozin contribute to improved cardiac function in experimental heart failure with reduced ejection fraction
|Cardiovascular Diabetology|2020|70
Culture-Modified Bone Marrow Cells Attenuate Cardiac and Renal Injury in a Chronic Kidney Disease Rat Model via a Novel Antifibrotic Mechanism
|PLoS ONE|2010|65
Transforming Growth Factor-β in Human Diabetic Nephropathy
|Diabetes Care|2006|54